Saxenda is the brand name for the medication liraglutide. Like Wegovy (semaglutide), Saxenda is also a glucagon-like peptide-1 receptor agonist (GLP-1 RA) used for chronic weight management in adults who have obesity or are overweight and have at least one weight-related condition.
Liraglutide works by mimicking the effects of GLP-1, a hormone that is naturally released in the body after eating. It helps regulate blood sugar levels and appetite. By activating GLP-1 receptors in the brain, liraglutide can reduce hunger and increase feelings of fullness, leading to weight loss.
Saxenda is administered as a subcutaneous injection (under the skin) once daily. It is typically used in combination with a reduced-calorie diet and increased physical activity. The specific dosage and treatment duration should be determined by a healthcare professional.
Clinical studies have shown that Saxenda can lead to significant weight loss in individuals with obesity. It is important to note that Saxenda is indicated for individuals with a body mass index (BMI) of 30 or higher or a BMI of 27 or higher with at least one weight-related condition.
As with any medication, Saxenda can have side effects. Common side effects may include nausea, vomiting, diarrhea, constipation, stomach pain, decreased appetite, headache, and fatigue. It is essential to discuss potential risks, benefits, and side effects with a healthcare provider before starting Saxenda.
Please bear in mind that my knowledge cutoff is in September 2021, and there may be more recent developments or information about Saxenda. It is always advisable to consult with a healthcare professional for the most up-to-date and personalized advice regarding any medication.